Moreover, it shows increased expression of FOXD1 in mesenchymal glioma stem cells and contributes to glial neoplasms by upregulating the expression of the aldehyde dehydrogenase isoform ALDH1A3 via directly activating its promoter (Cheng et al. 2016). This evidence concerns the gene FOXD1 and central nervous system cancer.